Jhpiego   Report issue

Foundation Phase 1 Phase 4
Founded: Baltimore MD United States (1973)

Organization Overview

First Clinical Trial
2011
NCT01096134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Jhpiego

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 4)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Malnutrition (Phase 4)

Premature Birth (Phase 4)

Sexually Transmitted Diseases (Phase 4)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 11